Association between endogenous sex hormones and cardiovascular-kidney-metabolic in US adults: a population-based study
摘要
The association between endogenous sex hormones and Cardiovascular-kidney-metabolic (CKM) syndrome remains incompletely elucidated.
MethodsWe performed a cohort study using clinical data from the National Health and Nutrition Examination Survey (NHANES) 2013–2016. Restricted cubic spline Cox proportional hazards models and stratified analyses were employed to analyze the relationships between sex hormone-binding globulin (SHBG), free androgen index (FAI), testosterone-to-estradiol ratio (T: E), and mortality.
ResultsIn a cohort of 2,545 patients with CKM (mean age 51.84 years; 63.65% male) followed for a mean of 4.78 years, stage 2 disease was the most prevalent (56.96%). A significant inverse correlation between advancing CKM stages and serum levels of testosterone-related parameters (all P < 0.05) was observed, alongside reduced estradiol and elevated SHBG. After multivariable adjustments, the association between FAI and all-cause mortality remained significant (HR = 0.46, 95% CI: 0.30–0.69, P < 0.001), whereas the effects of SHBG and the T: E ratio were diminished (P > 0.05). However, for CVD mortality, no significant results were observed in multivariable adjustments. In men aged > 60 years, elevated FAI (> 25.91 nmol/L) and T: E ratio (> 1.55) were each independently associated with reduced all‑cause mortality, with adjusted HRs of 0.24 (P = 0.02) and 0.51 (P = 0.01), respectively.
ConclusionsCox proportional hazards analysis demonstrated an inverse relationship between serum FAI and all-cause mortality in the overall, postmenopausal and men (> 60 years) CKM subgroup. In addition, a higher T: E ratio was inversely associated with all‑cause mortality specifically in men aged > 60 years with CKM.